Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. - Wikidata - awgldk - TriplyDB

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

http://www.wikidata.org/entity/Q45113233

about

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Statins for the primary prevention of cardiovascular disease Statins for the primary prevention of cardiovascular disease HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses Monitoring kidney function and albuminuria in patients with diabetes.Vascular calcification: When should we interfere in chronic kidney disease patients and how?Statins in the treatment of chronic heart failure: a systematic review Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Primary prevention of CVD: treating dyslipidaemia.Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.Disorders of lipid metabolism and chronic kidney disease in the elderly Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients.World kidney day 2011: protect your kidneys, save your heart.Predictors of urinary albumin excretion in women with polycystic ovary syndrome Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH.Predicting hospital cost in CKD patients through blood chemistry values Predicting the outcome of chronic kidney disease by the estimated nephron number: the rationale and design of PRONEP, a prospective, multicenter, observational cohort study.Renal protection in diabetes: lessons from ONTARGET.Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease.Safety of ACE inhibitor therapies in patients with chronic kidney disease.Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?Association of renal biomarkers with 3-month and 1-year outcomes among critically ill acute stroke patients.A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.Chronic kidney disease: a public health problem that needs a public health action plan High-normal albuminuria and risk of heart failure in the community.Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter regist Predictors of incident albuminuria in the Framingham Offspring cohort.Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis.World Kidney Day 2011 - Protect your kidneys, save your heart.Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.Emerging drug combinations to optimize renovascular protection and blood pressure goals.The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function.Albuminuria-reducing effect of angiotensin II receptor blocker plus hydrochlorothiazide combination therapy in renal transplant recipients

P2860

Q24194514-0E4E6ECE-1291-4FB2-9954-FC4B15547F60 Q24201513-E7484FD4-2EDF-4C98-B512-CC625AA85E9D Q24234813-C1FBB646-16C3-4CAC-A641-3F8483E5E475 Q24241472-A86CB362-0C33-43DC-9B7F-E14644A64B98 Q24628361-091BCE59-E376-4056-8F30-72EF1B748A5D Q24646234-04745DC4-F7C9-4B85-8F71-3E2E0B1E9D25 Q26996563-CDA09093-5B5A-4A53-8DF0-5D5B819959BE Q27691297-2D9A2975-43AA-4EF6-8AD0-9A0B1BC42C97 Q28071582-E22785AC-8C70-4221-9E5A-066C25B918E2 Q28200294-BDA146D1-F5DE-48A7-BD3D-7469A0DA2542 Q28483807-0D30B111-AE62-475C-BD90-4EA3AC3D8D91 Q30234324-8D94F602-B438-45E7-BD3F-0F196CA33589 Q33446730-984AABA8-C0F7-4FD2-999E-064088E99773 Q33588706-41072FB6-917C-4C3E-AE27-0F5CD3377F16 Q33589563-4063FDCD-141F-40A6-8E71-26E2B70E64F7 Q33692733-AE08F2BA-BE16-4041-8E32-3129A98A6BE4 Q33813773-F9426277-5CE8-45BF-875D-B804E40AD03A Q33871733-FB225DB0-D6D5-49C0-8D0D-67464C280AE7 Q33889835-179EF580-887F-4E6D-8137-0C104E9CE060 Q34013444-6FB03848-B4A2-4B36-A3C0-9B0DE6CB5FC2 Q34088691-C33C33BE-867A-4072-BF12-ED4355111D4C Q34190377-916097B3-394E-474B-9599-85553365AE9B Q34221460-198EEE29-112D-462F-A78A-780BDEDB0B32 Q34407904-AD16F829-474A-4109-A3E9-FBB4D3861B33 Q34434606-EE3854FA-2905-4065-A88B-6E98BFEB3B03 Q34613884-BC2DD764-B93F-4BFD-BF7A-DDD9E479FE73 Q34980234-99719982-AAC9-418D-B6EE-265953BEC449 Q34994258-97B52A48-5A8B-4DCA-9455-238C6B524493 Q35023531-FBED763B-C787-4F55-8B15-4CBDE2A0EB25 Q35024506-9B12D7DF-70A8-491E-96C1-900D35E83EE6 Q35058809-D7B715B8-738C-4D4C-AB3E-5040A48DDFA9 Q35224623-0EFE0B14-99B8-4591-BA6A-2CA3E008F8A5 Q35404652-339493AF-8E3A-4872-9B9C-54C8964DA983 Q35576102-BF02379C-CADE-48CE-A974-FA5077987BB1 Q35673984-1BAB266A-D5F8-44CC-976D-77861C124F66 Q35856929-84CA0302-92FC-4EC9-A564-8D6C7FE9194D Q35905899-35217E10-4FF5-44FE-BD7E-28DBBD748A67 Q36017400-1E03CBEE-7A37-4421-B810-5F3C45902F7C Q36087862-C5940C0D-945C-4FD0-A914-D2E824578E4E Q36285590-EB0914BF-105A-430E-8D8B-E6747976615D

P2860

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

http://www.wikidata.org/entity/Q45113233

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@en

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@nl

type

label

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@en

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@nl

prefLabel

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@en

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@nl

P1433

Q45113233-FC469970-6836-42DE-B916-09C4DF9DB55F

P1476

Q45113233-1EFA4627-9CC4-4C2A-A904-84EF8E4D51EA

P2093

Q45113233-01742FF2-6FC1-44EA-96EA-ED0C8926C38E

Q45113233-08D2E8D3-7323-459C-B21A-C2560AE4EBD2

Q45113233-7413EB1F-FFDE-4E5E-8AFB-AB569586081B

Q45113233-7D71EFD4-BAA5-4A86-82FB-E138671AB379

Q45113233-9CAEDBF1-B3AC-4C1D-9C88-4183EAADC782

Q45113233-A42C71A7-2F27-4F1A-B37C-0D28956E52ED

Q45113233-AD251299-2383-4792-AE6B-171572989554

Q45113233-F077AC46-9953-4D5C-8597-CDBCE28A6DED

P304

Q45113233-A4EC79F0-4EEF-4F25-B253-7201AD2D171B

P31

Q45113233-71FB0142-B37E-42F4-A531-F242561AF8E1

P356

Q45113233-C8C34898-E216-4572-B7C4-5E64D383DF38

P407

Q45113233-E8FBDB0D-6F90-421C-8779-26A761B72B44

P433

Q45113233-90F1C9F5-8C1F-428C-A749-CFCB4500BD33

P478

Q45113233-AF73FB76-CEC3-42CD-880F-4426130BD1CD

P50

Q45113233-3ED94D4A-9D2B-4691-AFB0-700DFA0F483A

Q45113233-70EE8F00-68E9-4018-B2E3-319C75B5FC35

Q45113233-850AEFB0-4A9A-4969-BDA5-78F489CC375C

P577

Q45113233-FAE2C5CF-650D-426E-87BF-346D4BBBC32E

P698

Q45113233-26C6C7FB-2C60-4BCD-A7EB-683E54B7A295

P921

Q45113233-0869B38B-05E5-4E2A-8943-AFDB5ADAB6F0

P356

01.CIR.0000146378.65439.7A

P1433

P1476

Effects of fosinopril and prav ...... ubjects with microalbuminuria.

@en

P2093

Ad J van Boven

http://www.w3.org/2001/XMLSchema#string

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Dick de Zeeuw

http://www.w3.org/2001/XMLSchema#string

Gilles F H Diercks

http://www.w3.org/2001/XMLSchema#string

Hans L Hillege

http://www.w3.org/2001/XMLSchema#string

Paul E de Jong

http://www.w3.org/2001/XMLSchema#string

Prevention of Renal and Vascul ...... ial (PREVEND IT) Investigators

http://www.w3.org/2001/XMLSchema#string

Wilbert M T Janssen

http://www.w3.org/2001/XMLSchema#string

P304

2809-2816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000146378.65439.7A

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Wiek H van Gilst

Folkert W. Asselbergs

Dirk J van Veldhuisen

P577

2004-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15492322

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio